Bristol-Myers Squibb

In June 2016, Bristol-Myers Squibb and PsiOxus partnered on a clinical collaboration to evaluate Enadenotucirev in combination with nivolumab to investigate their use in several tumor types (the SPICE Study). View the collaboration announcement.


Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image
Menu